Further analysis demonstrated that GBM Treg cells acquired a Th1-like signature, including increased Tbx21, Stat4, and IL12rb1 expression51, which may have contributed to de novo acquisition of antitumor function (Fig. 3c, d). The gene discussed is STAT4; the disease is glioblastoma.